NUTEX HEALTH Presents at the 43rd JP MORGAN HEALTHCARE Conference By Investing.com

houston, January 6, 2025 /PRNewswire/ — Nutex Health Inc. (“Newtex Health” or the “Company”) (NASDAQ: NUTX) is a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art small hospitals and a network of primary care-focused, risk-bearing physicians in 11 states. Makes the industry’s largest healthcare investment today “I announced that I would be presenting at the symposium.” 43^rd annual JP Morgan Healthcare Conference. This event will be held from the following. January 13th^Day up to 16^Day to San Francisco, California.

Nutex Health Presentation Details:

Date: Thursday, January 16, 2025
hour: 10:30 AM “ 11:10 AM Pacific Time
location: Elizabeth B Conference Room to Westin St. Francis Hotel to san francisco

In addition to formal presentations, company executives may participate in one-on-one meetings with qualified members of the investor community who have registered to attend the conference.

for Nutex Health Inc.

It is headquartered in Houston, Texas and was founded in 2011. Nutex Health Inc. (NASDAQ: NUTX) has a hospital division and National Health Management Department.

The Hospitals division owns, develops and operates innovative medical centers, including small hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The division owns and operates 24 facilities in 11 states.

The Population Health Management Division owns and operates the following provider networks: independent (LON:) Institute of Physicians (IPA).

Forward-Looking Statements

Certain statements and information contained in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. Words or phrases used in this press release include “will,” “results are likely to be achieved,” “is expected to be,” “will continue,” “is expected,” “estimated,” ” The words ‘anticipate’, ‘intend’, ‘target’ or similar expressions are intended to identify ‘forward-looking statements’ within the meaning of the Privacy Policy, whether known or unknown in such statements. certain risks and Uncertainties apply, many of which are beyond the Company’s control, including, but not limited to, its ability to successfully execute its growth strategy, the interim final and final rules implemented under the No Surprises Act; including, but not limited to, changes in laws or regulations, economic conditions, dependence on management, dilution of value, and the impact on shareholders, lack of capital, rapid growth, and the effective growth and demand for the Company’s products and services. Management’s ability to respond, newly developed Technology, the Company’s ability to compete, related party dealings, regulatory issues, technology protections, lack of industry standards, the impact of competition and the Company’s ability to obtain future financing is an extensive list of factors that may affect future results. This is discussed in our Annual Report on Form 10-K for the year in which it was filed. December 31, 2023 Quarterly Report on Form 10-Q for the period ended. March 31, 2024, June 30, 2024 and September 31st2024 Part 1, Item IA, titled “Risk Factors” and such other documents as may be filed from time to time. Securities and Exchange Commission. These factors could have a material adverse effect on the Company’s financial performance and could cause the Company’s actual results in the future to differ materially from any opinions or statements expressed in this press release.